Acrospire Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
2017
Q1
$10K Sell
2016
Q4
$332K Buy
2016
Q3
$267K Buy
2016
Q2
$180K Buy
2016
Q1
$93K Buy